Madeleine E Lemieux

Title: Innovations by Madeleine E. Lemieux in Lung Cancer Detection

Introduction

Madeleine E. Lemieux is an accomplished inventor based in Plantagenet, CA. She has made significant contributions to the field of medical technology, particularly in the early detection of lung cancer. Her innovative approach combines automated flow cytometry and machine learning to enhance diagnostic accuracy.

Latest Patents

Madeleine holds a patent for a groundbreaking system and method for detecting early-stage lung cancer in sputum samples. This patent, which is titled "Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning," outlines a comprehensive process. The method involves obtaining a plurality of cells from a sputum sample, marking these cells with specific marker compositions, and analyzing them using a flow cytometer. The process culminates in generating a classification for the sputum sample, distinguishing between cancerous and non-cancerous conditions.

Career Highlights

Madeleine is currently associated with Bioaffinity Technologies, Inc., where she continues to develop innovative solutions in cancer diagnostics. Her work is characterized by a commitment to improving patient outcomes through advanced technology. With her expertise, she has positioned herself as a leader in the field of medical diagnostics.

Collaborations

Madeleine collaborates with Vivienne I. Rebel, a fellow innovator in the field. Together, they work on projects that aim to push the boundaries of current medical technologies and improve diagnostic methods.

Conclusion

Madeleine E. Lemieux's contributions to lung cancer detection exemplify the power of innovation in healthcare. Her patented technology represents a significant advancement in the early diagnosis of lung cancer, showcasing her dedication to improving medical outcomes.